Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 181 - 200 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9 10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Dr. Benjamin Domb Announces the Opening of the American Hip Institute

DES PLAINES, Ill., Feb. 14, 2019 /PRNewswire/ -- Setting a new standard for medical specialization, the American Hip Institute (AHI) is the first clinic in the nation dedicated exclusively to cutting edge, minimally-invasive treatment of the sports injuries and arthritis of the hip. Dr. Benjamin... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2019

$4 Bn Veterinary Diagnostics Market by Product, Technology, Animal, End User - Global Forecast to 2023 with IDEXX Laboratories and Abaxis Dominating

DUBLIN, Feb. 14, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2019

Prometic retains investment bank for strategic transactions

LAVAL, QC, Feb. 14, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI), (OTCQX: PFSCF) ("Prometic" or the "Corporation") today announced that it has engaged Lazard to review and execute key strategic transactions for the Corporation... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2019
Related companies:  Prometic Life Sciences Inc.

Liht Cannabis Corp. To Exclusively Use Leading-Edge Lighting Technology By Agnetix In British Columbia Cultivation Facilities

KELOWNA, BC, Feb. 14, 2019 /PRNewswire/ - Liht Cannabis Corp. (CSE: LIHT) (OTCQX: LIHTF) or the "Company") has selected the innovative Agnetix liquid cooled LED lighting system for its British Columbia, Canada cultivation facilities.

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2019
Related companies:  Liht Cannabis Corp.

Cannabis Businesses Eye Latin America in Effort to Reduce Costs

FinancialBuzz.com News Commentary

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2019

BIOREM Announces International Expansion of Distribution Network

GUELPH, ON, Feb. 14, 2019 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced distribution expansion into two new geographic areas. The expansion is part of a concerted global sales growth initiative.

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2019
Related companies:  Biorem Technologies Inc.

Addex and Indivior to Accelerate Additional GABAB PAM Compounds for Addiction as Indivior Elects to Stop Development of ADX71441

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2019
Related companies:  Addex Therapeutics S.A.

Motif Bio Receives Complete Response Letter from the FDA

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2019

Ossur Hf : Annual General Meeting 7 March 2019

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2019
Related companies:  Össur Nordic AB | Össur Germany | Össur Americas, Inc.

Terveystalo Plc: Terveystalo Group Financial Statements Bulletin 2018

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2019

Terveystalo Plc: Notice of the Annual General Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2019

Active Biotech Year-end report January - December 2018

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2019
Related companies:  Active Biotech AB

Martin Åmark, CEO for Xbrane Biopharma AB, becomes Head of IR for the Company

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2019
Related companies:  Xbrane Biopharma AB

Amarin to Present at the 8th Annual SVB Leerink Global Healthcare Conference

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2019
Related companies:  Amarin Corporation plc

SK Biopharmaceuticals and Arvelle Therapeutics Announce Agreement to Develop and Commercialize Cenobamate in Europe

GYEONGGI, South Korea, Feb. 14, 2019 /PRNewswire/ -- SK Biopharmaceuticals and Arvelle Therapeutics GmbH today announced that they have entered into an exclusive licensing agreement for Arvelle to develop and commercialize cenobamate in Europe. Cenobamate is a novel, small molecule investigational... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2019

New Scientific Research Provides Link Between Globo-series Glycosphingolipid (GSL) Antigens and Tumor Survival in Breast Cancer

TAIPEI, Taiwan, Feb. 14, 2019 /PRNewswire/ -- A team led by Dr. Chi-Huey Wong, Distinguished Research Fellow, Academia Sinica in Taiwan, in collaboration with OBI scientists, has demonstrated in a recent study that the Globo-series glycosphingolipid (GSL) antigens: Globo-H, SSEA-3, and SSEA-4... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2019
Related companies:  OBI Pharma, Inc. | Mimosa OBI AS | OBI Medical ApS | OBI Pharma, Inc.

Alvogen   i Lotus lanseaza primul medicament biosimilar generic al capsulelor tari de Revlimid(TM) in anumite state europene

PINE BROOK, New Jersey, February 14, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2019
Related companies:  Alvogen Korea Co., Ltd. | Alvogen | Alvogen Luxembourg | Alvogen CEE Ltd.

Gerresheimer Back on Growth Path and Sets Course for the Future

DÜSSELDORF, Germany, February 14, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2019

Beijing Intellectual Property Court Confirms Judgment Against Wuxi Hisky Medical for Patent Infringement of Technology Used for Echosens' FibroScan®, Imposes Damages & Orders Halt to Manufacturing and Sales

PARIS, February 14, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2019

BioArctic - Full Year Report January - December 2018

STOCKHOLM, Feb. 14, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2019
Related companies:  BioArctic AB
«  1  2  3  4  5  6  7  8  9 10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑